Cargando…
A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information
BACKGROUND: Home-based rapid diagnostic testing can play an integral role in controlling the spread of coronavirus disease 2019 (COVID-19). OBJECTIVES: This review aimed to identify and compare at-home diagnostic tests that have been granted Emergency Use Authorizations (EUAs) and convey details abo...
Autores principales: | Kepczynski, Casey M., Genigeski, Jaelin A., Koski, Renee R., Bernknopf, Allison C., Konieczny, Alison M., Klepser, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196235/ https://www.ncbi.nlm.nih.gov/pubmed/34274214 http://dx.doi.org/10.1016/j.japh.2021.06.012 |
Ejemplares similares
-
Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: A diagnostic accuracy study
por: Kepczynski, Casey M., et al.
Publicado: (2021) -
Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement
por: Hohmeier, Kenneth C., et al.
Publicado: (2022) -
Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability
por: Adams, Alex J., et al.
Publicado: (2021) -
State Approaches to Therapeutic Interchange in Community Pharmacy Settings: Legislative and Regulatory Authority
por: Vanderholm, Thomas, et al.
Publicado: (2018) -
Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities
por: Klepser, Nicklas S., et al.
Publicado: (2021)